Clearside Biomedical Inc.(CLSD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CLSD Clearside Biomedical Inc.

退市 12-05 16:00:00 EST

0.4100

+0.0000

0.00%

最高0.4100	最低0.4100	成交量0.00
今开0.4100	昨收0.4100	日振幅0.00%
总市值214.59万	流通市值186.18万	总股本523.40万
成交额0.00	换手率0.00%	流通股本454.09万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CLSD","market":"US","secType":"STK","nameCN":"Clearside Biomedical Inc.","latestPrice":0.41,"timestamp":1764968400000,"preClose":0.41,"halted":4,"volume":0,"delay":0,"floatShares":4540931,"shares":5233981,"eps":-5.045186,"marketStatus":"退市","change":0,"latestTime":"12-05 16:00:00 EST","open":0.41,"high":0.41,"low":0.41,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-5.045186,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1464840000000,"exchange":"NASDAQ","adjPreClose":0.41,"volumeRatio":0},"requestUrl":"/m/hq/s/CLSD","defaultTab":"news","newsList":[{"id":"2586176491","title":"Clearside Biomedical, Inc.股价重挫69.85% 市值跌299.87万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586176491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586176491?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:31","pubTimestamp":1763994711,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日22时31分，Clearside Biomedical, Inc.股票出现异动，股价急速下跌69.85%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124223151a70e8a47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124223151a70e8a47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLSD","KTTA","BK4007","CLSDQ"],"gpt_icon":0},{"id":"2581445085","title":"Clearside Biomedical, Inc.盘中异动 股价大涨8.09%报4.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581445085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581445085?lang=zh_cn&edition=full","pubTime":"2025-11-05 23:07","pubTimestamp":1762355269,"startTime":"0","endTime":"0","summary":"北京时间2025年11月05日23时07分，Clearside Biomedical, Inc.股票出现异动，股价快速拉升8.09%。截至发稿，该股报4.00美元/股，成交量4242股，换手率0.08%，振幅1.35%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105230749a48af1a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105230749a48af1a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2574487104","title":"Clearside Biomedical, Inc.盘中异动 大幅跳水5.28%报4.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574487104","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574487104?lang=zh_cn&edition=full","pubTime":"2025-10-10 23:27","pubTimestamp":1760110047,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日23时27分，Clearside Biomedical, Inc.股票出现异动，股价快速跳水5.28%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101023272894c210ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101023272894c210ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2569490617","title":"Clearside Biomedical, Inc.盘中异动 大幅跳水5.47%报4.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2569490617","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569490617?lang=zh_cn&edition=full","pubTime":"2025-09-24 00:13","pubTimestamp":1758644001,"startTime":"0","endTime":"0","summary":"北京时间2025年09月24日00时13分，Clearside Biomedical, Inc.股票出现异动，股价大幅下跌5.47%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为1.05%。其相关个股中，Galecto, Inc.、木薯科学、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Galecto, Inc.、Silo Pharma, Inc.、Soligenix, Inc.较为活跃，换手率分别为3676.62%、342.35%、169.07%，振幅较大的相关个股有Adverum Biotechnologies, Inc.、Galecto, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为47.68%、40.33%、38.68%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092400132195407b36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092400132195407b36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007","GLTO","BK4139"],"gpt_icon":0},{"id":"2566995563","title":"Clearside Biomedical, Inc.盘中异动 股价大跌7.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566995563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566995563?lang=zh_cn&edition=full","pubTime":"2025-09-11 03:34","pubTimestamp":1757532890,"startTime":"0","endTime":"0","summary":"北京时间2025年09月11日03时34分，Clearside Biomedical, Inc.股票出现波动，股价大幅跳水7.88%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509110334509786d9ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509110334509786d9ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"1182081868","title":"Clearside Biomedical Inc：出售方就SCS微注射器资产获得额外300万美元——SEC申报文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1182081868","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182081868?lang=zh_cn&edition=full","pubTime":"2025-09-08 19:19","pubTimestamp":1757330356,"startTime":"0","endTime":"0","summary":"根据SEC申报文件显示，Clearside Biomedical Inc的出售方就SCS微注射器资产获得了额外300万美元的收入。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"1161020727","title":"Clearside Biomedical Inc.于9月4日与Healthcare Royalty Partners签订修订协议 - SEC文件显示","url":"https://stock-news.laohu8.com/highlight/detail?id=1161020727","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161020727?lang=zh_cn&edition=full","pubTime":"2025-09-08 19:18","pubTimestamp":1757330295,"startTime":"0","endTime":"0","summary":"根据SEC文件显示，Clearside Biomedical Inc.于9月4日与Healthcare Royalty Partners签订了修订协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2558866693","title":"Clearside Biomedical, Inc.盘中异动 早盘股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558866693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558866693?lang=zh_cn&edition=full","pubTime":"2025-08-11 22:12","pubTimestamp":1754921564,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日22时12分，Clearside Biomedical, Inc.股票出现异动，股价急速下跌5.35%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Equillium, Inc.、Entero Therapeutics Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为4110.91%、353.02%、114.06%，振幅较大的相关个股有Entero Therapeutics Inc.、Equillium, Inc.、Jyong Biotech Ltd.，振幅分别为74.27%、70.68%、58.29%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081122124494dcd017&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081122124494dcd017&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2558031005","title":"Clearside Biomedical, Inc.8月8日成交额为17.41万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558031005","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558031005?lang=zh_cn&edition=full","pubTime":"2025-08-09 09:42","pubTimestamp":1754703749,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Clearside Biomedical, Inc.成交额为17.41万美元，成交额较昨日减少27.04%，当日成交量为43.17万股。Clearside Biomedical, Inc.于2025年8月8日涨6.4%，报0.408美元，该股过去5个交易日涨6.15%，年初至今跌57.09%，过去60日跌54.71%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-08|17.41万|-27.04%|43.17万|#|2025-08-07|23.87万|102.04%|61.10万|#|2025-08-06|11.81万|-37.39%|28.65万|#|2025-08-05|18.87万|-48.64%|45.02万|#|2025-08-04|36.74万|12.52%|85.83万|Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809094240a6dbe4a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809094240a6dbe4a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2557486516","title":"Clearside Biomedical, Inc.8月7日成交额为23.87万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557486516","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557486516?lang=zh_cn&edition=full","pubTime":"2025-08-08 09:41","pubTimestamp":1754617290,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日，Clearside Biomedical, Inc.成交额为23.87万美元，成交额较昨日增加102.04%，当日成交量为61.10万股。Clearside Biomedical, Inc.于2025年8月7日跌7.08%，报0.383美元，该股过去5个交易日跌8.13%，年初至今跌59.67%，过去60日跌57.0%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-07|23.87万|102.04%|61.10万|#|2025-08-06|11.81万|-37.39%|28.65万|#|2025-08-05|18.87万|-48.64%|45.02万|#|2025-08-04|36.74万|12.52%|85.83万|#|2025-08-01|32.65万|27.38%|82.68万|Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808094132a47c0927&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808094132a47c0927&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2557293581","title":"Clearside Biomedical, Inc.8月6日成交额为11.81万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557293581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557293581?lang=zh_cn&edition=full","pubTime":"2025-08-07 09:40","pubTimestamp":1754530821,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，Clearside Biomedical, Inc.成交额为11.81万美元，成交额较昨日减少37.39%，当日成交量为28.65万股。Clearside Biomedical, Inc.于2025年8月6日跌3.37%，报0.412美元，该股过去5个交易日跌8.38%，年初至今跌56.6%，过去60日跌52.0%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-06|11.81万|-37.39%|28.65万|#|2025-08-05|18.87万|-48.64%|45.02万|#|2025-08-04|36.74万|12.52%|85.83万|#|2025-08-01|32.65万|27.38%|82.68万|#|2025-07-31|25.63万|-72.07%|59.79万|Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807094027a479c05b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807094027a479c05b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2557349527","title":"Clearside Biomedical, Inc.8月5日成交额为18.87万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557349527","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557349527?lang=zh_cn&edition=full","pubTime":"2025-08-06 09:38","pubTimestamp":1754444337,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日，Clearside Biomedical, Inc.成交额为18.87万美元，成交额较昨日减少48.64%，当日成交量为45.02万股。Clearside Biomedical, Inc.于2025年8月5日涨2.79%，报0.427美元，该股过去5个交易日跌11.1%，年初至今跌55.08%，过去60日跌49.74%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-05|18.87万|-48.64%|45.02万|#|2025-08-04|36.74万|12.52%|85.83万|#|2025-08-01|32.65万|27.38%|82.68万|#|2025-07-31|25.63万|-72.07%|59.79万|#|2025-07-30|91.77万|-50.36%|195.69万|Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806093907a47795a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806093907a47795a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2556382199","title":"Clearside Biomedical, Inc.盘中异动 大幅上涨7.50%报0.413美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556382199","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556382199?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:31","pubTimestamp":1754314275,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时31分，Clearside Biomedical, Inc.股票出现异动，股价大幅上涨7.50%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Psyence Biomedical Ltd.、Soligenix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为2110.89%、759.04%、372.23%，振幅较大的相关个股有凯信远达、Camp4 Therapeutics Corporation、Soligenix, Inc.，振幅分别为15.35%、9.08%、8.57%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213115a6d28292&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213115a6d28292&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2556381119","title":"Clearside Biomedical, Inc.盘中异动 早盘大幅下跌6.39%报0.390美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556381119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556381119?lang=zh_cn&edition=full","pubTime":"2025-08-01 21:33","pubTimestamp":1754055193,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日21时33分，Clearside Biomedical, Inc.股票出现异动，股价急速下挫6.39%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801213313a6cdebf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801213313a6cdebf3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2555079361","title":"Clearside Biomedical, Inc.7月30日成交额为91.77万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555079361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555079361?lang=zh_cn&edition=full","pubTime":"2025-07-31 09:38","pubTimestamp":1753925897,"startTime":"0","endTime":"0","summary":"美东时间2025年7月30日，Clearside Biomedical, Inc.成交额为91.77万美元，成交额较昨日减少50.36%，当日成交量为195.69万股。Clearside Biomedical, Inc.于2025年7月30日跌6.25%，报0.45美元，该股过去5个交易日跌23.08%，年初至今跌52.63%，过去60日跌48.28%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-30|91.77万|-50.36%|195.69万|#|2025-07-29|184.86万|196.89%|360.59万|#|2025-07-28|62.27万|-49.20%|137.97万|#|2025-07-25|122.56万|-65.71%|236.76万|#|2025-07-24|357.44万|-97.19%|655.60万|Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731093836a6ca8a15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731093836a6ca8a15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2555683200","title":"Clearside Biomedical, Inc.盘中异动 股价大涨5.59%报0.470美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555683200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555683200?lang=zh_cn&edition=full","pubTime":"2025-07-29 23:56","pubTimestamp":1753804589,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日23时56分，Clearside Biomedical, Inc.股票出现波动，股价快速上涨5.59%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729235629a6c82257&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729235629a6c82257&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2554377216","title":"Clearside Biomedical, Inc.盘中异动 早盘急速下跌7.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554377216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554377216?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:35","pubTimestamp":1753709714,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时35分，Clearside Biomedical, Inc.股票出现波动，股价急速下跌7.16%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Celcuity Inc.、Aim Immunotech Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 涨幅较大，Aim Immunotech Inc.、Tnf Pharmaceuticals, Inc.、Cervomed Inc.较为活跃，换手率分别为222.64%、85.60%、83.54%，振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为35.83%、30.65%、20.41%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072821351497234e8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072821351497234e8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2553122409","title":"Clearside Biomedical, Inc.7月23日成交额为1.27亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553122409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553122409?lang=zh_cn&edition=full","pubTime":"2025-07-24 09:36","pubTimestamp":1753321007,"startTime":"0","endTime":"0","summary":"美东时间2025年7月23日，Clearside Biomedical, Inc.成交额为1.27亿美元，成交额较昨日增加20527.33%，当日成交量为2.28亿股。Clearside Biomedical, Inc.于2025年7月23日涨66.48%，报0.585美元，该股过去5个交易日跌30.02%，年初至今跌38.42%，过去60日跌30.52%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-23|1.27亿|20527.33%|2.28亿|#|2025-07-22|61.58万|-68.04%|173.86万|#|2025-07-21|192.64万|17.93%|597.37万|#|2025-07-18|163.35万|-26.65%|366.34万|#|2025-07-17|222.68万|4156.78%|378.62万|Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724093757a4601ccf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724093757a4601ccf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2552202961","title":"Clearside Biomedical, Inc.盘中异动 下午盘股价大涨5.15%报0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552202961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552202961?lang=zh_cn&edition=full","pubTime":"2025-07-17 03:09","pubTimestamp":1752692949,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日03时09分，Clearside Biomedical, Inc.股票出现波动，股价急速上涨5.15%。截至发稿，该股报0.870美元/股，成交量5.4842万股，换手率0.07%，振幅5.02%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为1.13%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071703091095452b58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071703091095452b58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2551133782","title":"Clearside Biomedical, Inc.盘中异动 下午盘股价大跌9.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551133782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551133782?lang=zh_cn&edition=full","pubTime":"2025-07-15 02:46","pubTimestamp":1752518810,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日02时46分，Clearside Biomedical, Inc.股票出现波动，股价大幅下挫9.59%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715024650a44a802a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715024650a44a802a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.clearsidebio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.8993},{"period":"3month","weight":-0.921},{"period":"6month","weight":-0.9652},{"period":"1year","weight":-0.9737},{"period":"ytd","weight":-0.9712}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Clearside Biomedical, Inc.于2011年5月26日在特拉华州注册成立。该公司是一个后期临床生物制药公司，开发先入类药物疗法来治疗眼睛的致盲疾病。公司目前的候选产品着力解决影响视网膜和脉络膜，尤其是黄斑水肿相关的疾病，并注入到使用其专有的SCS微量注射器脉络膜上腔。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.035821},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.036687},{"month":3,"riseRate":0.555556,"avgChangeRate":0.062704},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.016766},{"month":5,"riseRate":0.222222,"avgChangeRate":-0.084718},{"month":6,"riseRate":0.777778,"avgChangeRate":0.150765},{"month":7,"riseRate":0.4,"avgChangeRate":-0.082191},{"month":8,"riseRate":0.3,"avgChangeRate":-0.078487},{"month":9,"riseRate":0.4,"avgChangeRate":0.107025},{"month":10,"riseRate":0.4,"avgChangeRate":0.039941},{"month":11,"riseRate":0.5,"avgChangeRate":-0.116261},{"month":12,"riseRate":0.333333,"avgChangeRate":0.048543}],"exchange":"NASDAQ","name":"Clearside Biomedical Inc.","nameEN":"Clearside Biomedical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Clearside Biomedical Inc.(CLSD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Clearside Biomedical Inc.(CLSD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Clearside Biomedical Inc.,CLSD,Clearside Biomedical Inc.股票,Clearside Biomedical Inc.股票老虎,Clearside Biomedical Inc.股票老虎国际,Clearside Biomedical Inc.行情,Clearside Biomedical Inc.股票行情,Clearside Biomedical Inc.股价,Clearside Biomedical Inc.股市,Clearside Biomedical Inc.股票价格,Clearside Biomedical Inc.股票交易,Clearside Biomedical Inc.股票购买,Clearside Biomedical Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Clearside Biomedical Inc.(CLSD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Clearside Biomedical Inc.(CLSD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}